Announcements Trials
Browse Landscape

Phase

Phase 4 3

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 5Gastritis 4Peptic Ulcer 3Dyspepsia 3Barrett Esophagus 3Stomach Ulcer 2Colorectal Neoplasms 2Peptic Ulcer Hemorrhage 1Gastrointestinal Stromal Tumors 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1Dysbiosis 1Colonic Neoplasms 1

Interventions

Bismuth 5Amoxicillin 4Tetracycline 3Esomeprazole 3Clarithromycin 3Furazolidone 2Rabeprazole 1Minocycline 1Berberine 11-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Dyspepsia × Esomeprazole × Clear all
NCT07139366 2025-12-02

Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment

Xijing Hospital of Digestive Diseases

Phase 4 Recruiting
1,248 enrolled
Gastrointestinal

Dyspepsia, Gastritis, Peptic Ulcer, Stomach Neoplasms

NCT05742568 2025-07-03

Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology

Xijing Hospital of Digestive Diseases

Phase 4 Completed
124 enrolled
Gastrointestinal

Dyspepsia, Gastritis, Peptic Ulcer, Stomach Neoplasms

NCT04678492 2023-01-31

Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

Xijing Hospital of Digestive Diseases

Phase 4 Completed
658 enrolled
Gastrointestinal

Dyspepsia, Gastritis, Peptic Ulcer, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡